Business Segments · Indefinite-lived trademarks

MedTech — Indefinite-lived trademarks

Analysis

StatementSegment
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2025
Last reportedQ4 2025

How to read this metric

An increase suggests successful brand acquisitions or revaluation, while a decrease may indicate impairment charges or the divestiture of key product lines.

Detailed definition

This metric represents the carrying value of intangible assets in the form of trademarks that are determined to have an...

Peer comparison

Peers in the medical device industry typically report these under intangible assets, often reflecting the strength of acquired intellectual property and brand portfolios.

Metric ID: jnj_segment_medtech_indefinite_lived_trademarks

Historical Data

1 periods
 Q4 '25
Value$1.70B

Frequently Asked Questions

What is Johnson & Johnson's medtech — indefinite-lived trademarks?
Johnson & Johnson (JNJ) reported medtech — indefinite-lived trademarks of $1.70B in Q4 2025.
What does medtech — indefinite-lived trademarks mean?
The total book value of brand trademarks that are expected to provide value to the company indefinitely.